SESEN BIO, INC.
Sesen Bio, Inc.. is a late clinical-stage company advancing a broad pipeline of novel anti-cancer agents based on their Targeted Protein Therapeutics (TPTs) platform. Their TPTs genetically combine targeting antibody fragments with cytoxic protein payloads to create a single fusion protein through Eleven's proprietary one-step manufacturing process.
SESEN BIO, INC.
Industry:
Biotechnology Health Care Medical Device
Founded:
2010-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sesenbio.com
Total Employee:
11+
Status:
Active
Contact:
(617) 871-9911
Email Addresses:
[email protected]
Total Funding:
163 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Apache Microsoft Exchange Online Office 365 Mail IPv6 Google Maps Microsoft Azure DNS Network Solutions DNS
Similar Organizations
Respiratory Motion
Respiratory Motion is a commercial-stage medical device company.
Rubedo Life Sciences
Rubedo Life Sciences mission is to treat age-related diseases to extend health-span targeting senescence and stem cells.
RenovoRx
RenovoRx is developing innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system.
ReShape Lifesciences
ReShape Lifesciencesis a developer of minimally invasive medical devices to treat obesity and metabolic diseases.
ni2o
Ni2o develops a brain implant to treat a variety of diseases.
Naked Biome
Naked Biome is a microbiome-based therapeutics company, launching advanced therapies to treat and prevent skin disease.
NICO
NICO develops medical devices for minimally invasive neurosurgery, as well as skull base and spinal surgical procedures.
Neurimmune Holding
Neurimmune develops innovative immunotherapeutics for human diseases.
Nimbus Apollo
Nimbus Apollo, Inc. research and develops drugs that treats non-alcoholic steatohepatitis.
NantWorks
NantWorks combines semiconductor technology, supercomputing and advanced networks to improve healthcare, commerce and digital entertainment.
VistaPath Biosystems
VistaPath Biosystems develops a tissue grossing platform that automates the process of inspecting, inking, and measuring tissues.
Vena Medical
Vena Medical creating a forward viewing imaging microcatheter that allows physicians to see inside patient blood vessels.
Versiti
Versiti provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related diseases.
Valeritas
Valeritas is the developer of V-GO, a disposable insulin pump, and a micro needle patch for the treatment of Type 2 diabetes.
MRL Ventures Fund
MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.
Moximed
Moximed improves the standard of care for patients with osteoarthritis and investigates therapies to treat affected joints.
Viridian Therapeutics
Viridian Therapeutics is a biotechnology company that offers treatments for patients suffering from diseases.
Quadrant Biosciences
Quadrant Biosciences develop, test, and distribute products with expertise in engineering, production, marketing, and sales.
Myomo
Myomo develops devices with myoelectric prosthetic technology to restore the mobility of individuals with muscle weakness.
Lungpacer Medical
Lungpacer Medical develops a novel therapeutic solution for preserving the integrity and strength of the diaphragm muscle.
Levita Magnetics
Levita Magnetics develops an innovative magnetic surgical platform that serves as a catalyst of less invasive surgery.
Lassen Therapeutics
Lassen Therapeutics is developing novel, best-in-class biotherapeutics to improve the lives of patients suffering from serious diseases.
Aptatek Biosciences
Aptatek is developing a biosensing platform for portable disease management devices.
Access Vascular
Access Vascular is a medical device company that develops novel bulk hydrophilic-based devices to improve venous access.
Arsenal Medical
Arsenal Medical develops novel products that improve local therapy for injuries and diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apnimed
Apnimed is a clinical-stage company dedicated to the discovery of novel pharmacologic therapies for sleep apnea and related disorders.
Aerin Medical
Aerin Medical is a health technology company that develops therapeutic devices to improve nasal breathing.
Allergenis
Allergenis is a develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose food allergy.
Austen BioInnovation Institute
Advance Value-Added, Patient-Centered Healthcare Solutions
.
Arch Therapeutics
Arch Therapeutics is a medical device company offering an innovative therapeutic approach to stasis and barrier applications.
American Renal Associates Holdings
American Renal Associates Holdings operates kidney dialysis services and offers outpatient and inpatient dialysis treatments.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Alpine Immune Sciences
Alpine Immune Sciences is an immunotherapy company focused on developing treatments for autoimmune and inflammatory diseases.
Apostle
Apostle Inc is a provider of innovative technologies and services for public health and life sciences.
Elcelyx Therapeutics
Elcelyx Therapeutics is developing nutrient sensing-based products for weight management and obesity-related metabolic disorders.
Electronic Caregiver Inc.
Health and emergency systems for connected care, remote patient monitoring and health management leveraging leading-edge technologies.
Evolve Biosystems
Evolve Biosystems specializes in providing microbiome-based products designed to develop, restore, and maintain.
Edimer Pharmaceuticals
Edimer Pharmaceuticals develops a treatment to improve the health and quality of life of families living with XLHED.
Benvenue Medical
Benvenue Medical is a biotech company developing innovative and minimally invasive surgical solutions for the treatment of spinal disorders.
Weavr Health
Weavr Health is revolutionizing blood collection beyond the point of care including patients’ homes.
BAROnova
BAROnova is a clinical-stage medical-device company focused on developing non-surgical non-pharmacologic devices to induce weight loss.
SpeciCare
Revolutionizing cancer care by collecting and storing LIVE tumor tissue, to first benefit the individual patient, then cancer research.
Biomeme
Biomeme is a real-time PCR thermocycler that attaches to iPhone 5s and enables DNA diagnostics and real-time disease surveillance.
Fermentalg
Fermentalg is engaged in the production of micro-algae for the agrifood, healthcare and energy markets.
FIRE1
FIRE1 and is based in Dublin, Ireland, will focus on developing novel therapeutic devices.
Bolder Surgical
Bolder Surgical serves health care providers by developing surgical instruments that allow access to confined and delicate structures.
Quantum Biosystems
Application of quantum mechanics to the development of innovative single-molecule DNA sequencers
Qlaris Bio
Qlaris Bio focuses on developing novel and innovative therapies for serious and debilitating ophthalmic diseases.
Klotho Therapeutics
Focused on development and commercialization of recombinant human Klotho proteins to prevent and treat kidney disease and other diseases.
Kanyos Bio
Kanyos Bio was founded with the goal of developing antigen-specific immune tolerance technology for two specific autoimmune indications.
Soundbite Medical Solutions
Soundbite is a medical device company developing products in the field of vessel preparation for management and treatment.
Senhwa Biosciences
Senhwa is a drug development company creating innovative therapies for cancer and related diseases.
Syndevrx
SynDevRx develops polymer-based drug conjugates for small molecule drug activity.
Silk Technologies
SILKTECH focuses on innovating and developing silk-derived protein (SDP) products for ophthalmic applications
Sigma Genetics, Inc
Sigma Genetics is building a non-invasive device that can deliver charged molecules, such as DNA, RNA, and proteins into patient cells
Synergy Biomedical
Synergy Biomedical is a medical device company that focuses on bringing innovative biomaterial-based products to the orthopedic market.
SOBR Safe
SOBR Safe is a developer of the patented non-invasive alcohol detection system.
Vaxcyte
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Celsee Diagnostics
Celsee Diagnostics is an innovator of cutting-edge products in the emerging liquid-biopsy field.
Dosist
Dosist is a developer of proprietary vaporizing dose-pens created to provide safe, targeted, and effective cannabis.
HAI Solutions Inc.
HAI Solutions focuses on building innovative medical devices in the area of intravenous care and vascular access.
iSTAR Medical
iSTAR Medical focuses on developing innovative ophthalmic implants for patients suffering from eye diseases.
Exact Imaging
Exact Imaging is the developer of the ExactVuâ„¢ system, the first micro-ultrasound operating at 29 MHz that provides unmatched resolution.
Impliant
Impliant, Inc. develops novel spine arthroplasty solutions for motion preservation. The company offers TOPS system.
InVivo Therapeutics
InVivo Therapeutics is a medical device company focused on developing restoration treatments for patients with spinal cord-injuries.
Ivantis
Ivantis is focused on developing an innovative treatment for glaucoma which includes eye drops, laser therapy, and surgery.
Gramercy Extremity Orthopedics
Gramercy Extremity Orthopedics specializes in providing inventory management, foot and ankle, implants, and product development.
GnuBIO
GnuBIO is a developer of scalable DNA sequencing technology for the diagnostic and applied markets.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
OptiMedica
OptiMedica Corporation develops performance-driven technologies for ophthalmologists in transforming their existing standards of care.
OncoCyte
OncoCyte is a biotech company helping save lives and improve outcomes by accelerating and optimizing the diagnosis and treatment of cancer.
Orreco
Orreco provides biomarker analysis for athletes, federations, and professional franchises.
Osseon Therapeutics
Osseon Therapeutics develops medical devices for minimally-invasive treatments of degenerative bone and joint diseases.
Xenex
Xenex offers Pulsed Xenon Full Spectrum, a UV disinfection solution that reduces the bacterial load associated with the risk for HAIs.
Ceterix Orthopaedics
Ceterix Orthopaedics develops novel surgical tools for arthroscopic procedures.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Biolidics
Biolidics is focused on the development of medical devices to improve cancer diagnostics and patient care.
CorTechs Labs
CorTechs Labs is a developer of a brain image analysis software used to offer better clinical insight through quantitative imaging.
Cue Biopharma
Cue Biopharma has developed a highly productive platform for the treatment of cancer and autoimmune disease.
Cognito Therapeutics
Cognito Therapeutics is a focused on discovering and developing new Alzheimer's treatments and preventive therapies.
Cerulean Pharma
Cerulean Pharma develops nanotechnology-based therapeutics for treating oncology, cardiovascular, autoimmune and inflammatory diseases.
Paragonix Technologies
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-09-21 | Viventia Bio | Viventia Bio acquired by Sesen Bio, Inc. | N/A |
Investors List
Cowen Group
Cowen Group investment in Post-IPO Equity - Sesen Bio, Inc.
JAFCO
JAFCO investment in Series A - Sesen Bio, Inc.
Flagship Pioneering
Flagship Pioneering investment in Series A - Sesen Bio, Inc.
Third Rock Ventures
Third Rock Ventures investment in Series A - Sesen Bio, Inc.
Flagship Pioneering
Flagship Pioneering investment in Series A - Sesen Bio, Inc.
Third Rock Ventures
Third Rock Ventures investment in Series A - Sesen Bio, Inc.
Official Site Inspections
http://www.sesenbio.com Semrush global rank: 1.82 M Semrush visits lastest month: 12.43 K
- Host name: 151.101.130.159
- IP address: 151.101.130.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Sesen Bio, Inc."
Sesen Bio
Sesen Bio is now Carisma Therapeutics. Click below to learn more about the merger. learn moreSee details»
Board of Directors • Groups - Sesen Bio
Honig led Pfizer’s commitment to patient safety by working across the organization to ensure regulatory effectiveness, quality control and compliance throughout all stages of product …See details»
Sesen Bio - Crunchbase Company Profile & Funding
Sesen Bio is a late clinical-stage company advancing a broad pipeline of novel anti-cancer agents based on their Targeted Protein Therapeutics (TPTs) platform.See details»
Sesen Bio Announces New Appointments to its Board of Directors
Jul 21, 2021 Honig led Pfizer’s commitment to patient safety by working across the organization to ensure regulatory effectiveness, quality control and compliance throughout all stages of …See details»
Sesen Bio Announces New Appointments to its Board of Directors
Jul 21, 2021 Vicineum is a locally administered targeted fusion protein composed of an anti-EpCAM antibody fragment tethered to a truncated form of Pseudomonas Exotoxin A, which is …See details»
Sesen Bio, Inc. - AnnualReports.com
Sesen Bio, Inc. is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The Company’s lead program, Vicinium®, also known as …See details»
Sesen Bio Stockholders Approve Merger with Carisma …
Mar 2, 2023 Sesen Bio has turned its primary focus to consummating a strategic transaction with the goal of maximizing stockholder value. Additionally, Sesen Bio is seeking a partner for the …See details»
Sesen Bio Company Profile 2024: Valuation, Investors
Sesen Bio General Information Description. Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer.See details»
executive-leadership • Groups - Sesen Bio
Jun 17, 2019 Thomas Cannell, DVM By orrbittadmin9763, 1st December 2021 Thomas Cannell serves as president and chief executive officer of Sesen Bio and member of the Sesen Bio …See details»
Sesen Bio to Host Webcast with Carisma Therapeutics to Discuss …
Feb 16, 2023 CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 16, 2023-- Sesen Bio, Inc. (Nasdaq: SESN) today announced that members of its management team will host a fireside …See details»
Sesen Bio and Carisma Therapeutics Announce Merger Agreement
Sep 21, 2022 Investors: Erin Clark, Vice President, Corporate Strategy & Investor Relations [email protected] Carisma Media Contact: Julia Stern (763) 350-5223 …See details»
Sesen Bio and Carisma Therapeutics Announce Substantial …
Dec 29, 2022 Investors: Erin Clark, Vice President, Corporate Strategy & Investor Relations [email protected] Carisma Media: Julia Stern (763) 350-5223 [email protected] Site …See details»
Sesen Bio, Inc. (SESN) CEO Thomas Cannell on Q1 2021 Results
May 10, 2021 Sesen Bio, Inc. (NASDAQ:SESN) Q1 2021 Results Earnings Conference Call May 10, 2021See details»
Sesen Bio Announces Anticipated Regulatory Path Forward for
Dec 8, 2021 Sesen Bio, a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced its anticipated …See details»
Team • Sesen Bio
Dec 1, 2021 Thomas Cannell, DVM By orrbittadmin9763, 1st December 2021 Thomas Cannell serves as president and chief executive officer of Sesen Bio and member of the Sesen Bio …See details»
Sesen Bio Receives Complete Response Letter from FDA for
Aug 13, 2021 Sesen Bio, a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that it received a …See details»
Sesen Bio Announces Significant Commercial Progress as the …
Jul 26, 2021 The Company has completed the hiring of ~25 talented internal employees to support the Company cross-functionally, as well as the hiring of 34 of 35 sales representatives …See details»
Careers - Sesen Bio
Please forward any fraudulent messages or job posts to [email protected]. Sesen Bio will not extend an offer without a personal interview and will never charge any money for …See details»
Sesen Bio weighs sale or merger options after dismal year - Fierce …
May 3, 2022 Sesen Bio is searching for business alternatives, including a potential sale, after a dismal last year has left its sole asset hanging by a thread.See details»